Clinical trial
CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone
NCT00401856 · Royal Brompton & Harefield NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00401856 |
|---|---|
| Title | CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone |
| Official title | A Randomised, Double-blinded, Placebo-controlled Trial Using Cardiovascular Magnetic Resonance (CMR) Scanning to Assess Remodelling and Regression of Fibrosis in Cardiomyopathy With Eplerenone |
| Lead sponsor | Royal Brompton & Harefield NHS Foundation Trust, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cardiomyopathy |
| Intervention type | Drug |
| Interventions | Eplerenone, Placebo |
| Enrollment | 42 |
| Start date | Dec 1, 2007 |
| Primary completion | Apr 2, 2013 |
| Completion | Apr 2, 2013 |
| First posted | Nov 22, 2006 |
| Last update posted | Sep 21, 2021 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: